SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-075304
Filing Date
2020-06-19
Accepted
2020-06-19 17:01:14
Documents
4
Period of Report
2020-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022881d1_8k.htm 8-K 45764
2 EXHIBIT 3.1 tm2022881d1_ex3-1.htm EX-3.1 8243
3 EXHIBIT 3.2 tm2022881d1_ex3-2.htm EX-3.2 9949
4 EXHIBIT 10.1 tm2022881d1_ex10-1.htm EX-10.1 6699
  Complete submission text file 0001104659-20-075304.txt   72152
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 20976384
SIC: 2834 Pharmaceutical Preparations